In the final portion of our discussion with Kimberly Kue-Tsemo, PharmD, she explores the key developments that could be the most significant push toward reducing pharmacy deserts.
|Videos|December 17, 2021
Expert Interviews: Winners of the SingleCare Best of the Best Pharmacy Awards
Did you miss our coverage of the 2021 SingleCare Best of the Best Pharmacy Awards? View all four interviews in our video gallery below.
Advertisement
Advertisement
Related to this article
In the second part of our interview with a collection of pharmacists from various backgrounds, they delve into the current developments highlighting the future of the profession.
Allison Schneider, MPH, provides a detailed update regarding pharmacies’ impact within Medicare price negotiations and the legislation further impacting businesses.
In part 2 of our discussion with Kimberly Kue-Tsemo, PharmD, she addresses the emergence of technology and the nuances behind its actual capabilities.
In part 2, Allison Schneider, MPH, discusses PBM and 340B reform that could compound pharmacies’ burden amid ongoing Medicare drug price negotiations.
Kimberly Kue-Tsemo, PharmD, explores the current state of US pharmacy deserts amid ongoing reform, evolution in practice, and more.
Allison Schneider, MPH, provides expertise on how IRA drug price negotiations have impacted pharmacies in 2026 and what’s to come in the years ahead.
Shantel Upshaw Houston shares tips to prevent burnout, explains how pharmacists fill gaps in care, and urges midcareer peers to mentor students.
Advertisement
Advertisement
Trending on Drug Topics
1
American Pharmacists Month: PBM Reform, Provider Status Key in Stopping Pharmacy Deserts
2
Pfizer Reports Strong Phase 2 Data for 25-Valent Pediatric PCV
3
PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule
4
HHS Lets Pharmacies Compound Peptides as FDA Writes Official Rule
5